Tricuspid valve disease is mainly represented by tricuspid regurgitation (TR), which is a
predictor of poor outcome. TR is usually secondary, caused by right ventricle pressure or …

Introduction: Redo surgery still is the treatment of choice for degenerated bioprosthesis.
However, as far as elderly patients with concomitant comorbidities are concerned, the …

Aims: The study sought to assess outcomes of transcatheter mitral valve-in-valve
implantation (TMVIV) for degenerated bioprostheses and transcatheter mitral valve-in-ring …

Objective Valve-in-valve (ViV) procedures are increasingly being considered as an
alternative to redo surgery for the treatment of degenerated bioprosthetic heart valves in …

Background The recourse to mitral valve-in-valve implantation is expected to rise
consistently owing to the increasing use of bioprostheses and to the risks related to redo …

As transcatheter aortic valve replacement (TAVR) has become routine, device
manufacturers and investigational cardiologists have set their sights on the mitral valve …

Procedure planning with transthoracic and transesophageal echocardiogram must be
complemented with a cardiac computed tomography angiography. A heart team evaluation …

A 70-year-old male underwent mitral transcatheter valve-in-valve implantation for a failed
bioprosthesis implanted 11 years earlier. In the first days following the procedure, he …

Over the last 10 years, the use of bioprosthetic valves increased to 78.4% of total valves
used, whereas the mechanical valve use declined to 20.5%[1]. However, bioprosthetic …

Transcatheter valve-in-valve mitral valve replacement provides treatment options to high-risk
patients but is subject to its own complications. We present the migration of a transcatheter …